Executive Profile

Randal Chase Ph.D. Chief Executive Officer of ImmunoVaccine Technologies Inc. and President of ImmunoVaccine Technologies Inc., Immunotope, Inc.

Age	Total Calculated Compensation	This person is connected to 4 Board Members in 4 different organizations across 9 different industries. See Board Relationships
62	--

Background

Dr. Randal D. Chase, Ph.D. served as the Chief Executive Officer and President of ImmunoVaccine Inc. from 2006 to April 14, 2011 and also served as its Acting Chief Financial Officer. Dr. Chase served as the President of Global Mandate of Shire Biologics, a division of Shire Pharmaceuticals Plc from May 2001 to 2004. Dr. Chase held senior positions at several pharmaceutical and biotechnology companies, including a number of leading vaccine companies. He served as Senior ... Vice President of Vaccines Operations of Biochem Pharma, which was acquired by Shire in 2001. He established an alliance with Berna Biotech for the sale of Hepatitis B vaccine in Europe and Fluviral vaccine in Asia. Dr. Chase served as the Chief Executive Officer and President of North American Vaccine Inc., since October 1998 and oversaw the sale of that North American Vaccine to Baxter International Inc. in 2000. He served for several years as the Chief Executive Officer and President of Pasteur Merieux Connaught ('PMC') in Canada and Chairman of PMC in Mexico. From July 1993 to January 1996, Dr. Chase was employed at QLT Phototherapeutics and held various positions including: Director, President and Chief Executive Officer, Vice President and Chief Operating Officer. He also served as the Senior Vice President of Technical Operations at Glaxo Canada Inc. He served as the Chief Executive Officer and President of Quadra Logic Technologies. Dr. Chase served as the Chief Executive Officer and President of Aventis Pasteur from January 1996 to October 1998. He also served as a Member of the Executive Committee for Aventis Pasteur (Worldwide). He served as an Executive Chairman of Molecular Templates Inc. He serves as the Chairman of the Board of Medicago Inc. He served as the Chairman of Aventis Pasteur (Mexico). He has been a Director of Medicago Inc. since 2004. He has been an Independent Non-Executive Director of Acambis PLC, since October 1, 2004. He serves as a Director at Pan-Provincial Vaccine Enterprise Inc. He has been a Member of Corporate Advisory Board of Advanced Proteome Therapeutics Corporation since June 20, 2012. He served as a Director of ImmunoVaccine Inc. from October 1, 2009 to April 14, 2011. He served as a Director of BIOTECanada. He served as a Director of ConjuChem Biotechnologies, Inc. (formerly ConjuChem Inc.), from 2004 to February 2, 2009. He served as a Director of North American Vaccine Inc. He served as a Director of Bioject Medical Technologies Inc., from April 2005 to December 18, 2009. He served as a Director of Rhone-Poulenc Canada (a pharmaceutical company). Dr. Chase holds a Bachelor's of Sciences degree (biochemistry) from Bishop's University and obtained in 1974. Dr. Chase has a Ph.D. in Biochemistry from the University of British Columbia and did a Post Doctorate Fellowship at the McArdle Cancer Institute at the University of Wisconsin. He attended an Executive Programme at the London Business School in the UK.

Corporate Headquarters 111 West Cooperative Way Georgetown, Texas 78626 United States Phone: 512-930-0304 Fax: 512-233-2709 Board Members Memberships Former Chief Executive Officer, President and Director North American Vaccine Director BIOTECanada Former Executive Chairman Molecular Templates, Inc. Director Pan-Provincial Vaccine Enterprise Inc. 2004-Present Independent Non Executive Director, Member of Nominations Committee, Member of Audit Committee and Member of Remuneration Committee Acambis plc 2004-Present Chairman and Member of Audit Committee Medicago Inc. 2004-2009 Former Director and Member of Audit Committee ConjuChem Biotechnologies, Inc. 2005-2009 Former Director, Chairman of Corporate Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee Bioject Medical Technologies Inc. 2009-2011 Former Chief Executive Officer and President ImmunoVaccine Inc. Education PhD University Of British Columbia BS Bishop's University Unknown/Other Education London Business School Other Affiliations Acambis plc Medicago Inc. North American Vaccine Bioject Medical Technologies Inc. ConjuChem Biotechnologies, Inc. University Of British Columbia London Business School Bishop's University ImmunoVaccine Inc. BIOTECanada Molecular Templates, Inc. Advanced Proteome Therapeutics Corporation Pan-Provincial Vaccine Enterprise Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.